News

Latest

More than 1,000 human resource leaders and partners convened this week at the annual conference of the AHA’s American Society for Health Care Human Resources Administration in Chicago.
by Rick Pollack
This is just one way AHA is working to help hospitals and health systems transform and advance health in America.
The Senate today voted 82-15 to approve a continuing resolution that funds the federal government through Nov. 21 and delays impending Medicaid cuts, among other provisions.
Senate Finance Committee leaders yesterday released the statutory text for the Prescription Drug Pricing Reduction Act of 2019 (S-2543), which closely mirrors the chairman’s mark that passed the committee in July.
At an AHA forum today in Denver, hospital and health system leaders shared how they are collaborating with other health care providers, payers, employers and community partners to deliver better care and value to consumers.
The Centers for Disease Control and Prevention today updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 805 in 46 states and the U.S. Virgin Islands, including 12 deaths.
The Centers for Disease Control and Prevention has released the final four courses in the 11-course STRIVE online training series to help health care organizations prevent healthcare-associated infections.
The AHA’s American Society for Health Care Engineering this week released a new tool to help health care facilities monitor energy use.
The Centers for Medicare & Medicaid Services today issued final rules reducing some regulatory burdens for providers participating in the Medicare and Medicaid programs, and revising discharge planning requirements for hospitals, critical access hospitals and home health agencies.
The AHA today voiced support for several policy changes in the physician fee schedule proposed rule for calendar year 2020 that would promote access to care, public health, quality and regulatory relief.
The House Energy and Commerce Subcommittee on Health today held a hearing to discuss four bills aimed at making prescription drugs more affordable for Americans.
The average annual premium for employer-sponsored family health coverage rose 5% this year to $20,576, including employer and worker contributions, according to the latest annual survey of employer-sponsored health insurance by the Kaiser Family Foundation.
A new report from the National Academies of Sciences, Engineering, and Medicine recommends actions for health care systems, government agencies and others to better integrate patients’ social needs into health care delivery.
Nearly 100 hospital and health system leaders today came together in Washington, D.C., to urge lawmakers to take action on critical issues facing patients and protect access to care.
The Centers for Medicare & Medicaid Services today released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2020 calendar year.
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA, during the UN General Assembly in New York for their commitment to combat antimicrobial resistance as part of The AMR Challenge.
The National Health Law Program and Indiana Legal Services yesterday filed a federal lawsuit challenging the administration for approving a Section 1115 waiver for Indiana that requires certain adults to work to maintain Medicaid coverage.
As part of Sepsis Awareness Month, the Centers for Disease Control and Prevention is encouraging patients and health care professionals to share educational materials from its Get Ahead of Sepsis campaign.
The AHA invites hospitals and health systems to participate in the Better Maternal Outcomes Rapid Improvement Network, a free six-month program focused on maternal outcomes and respectful care.
The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards.